Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−21.248 CHF
−314.57 M CHF
0.00 CHF
18.38 M
About Madrigal Pharmaceuticals, Inc.
Sector
CEO
William J. Sibold
Headquarters
West Conshohocken
Website
Founded
2000
FIGI
BBG00LVDXMH7
Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca Taub and Edward Chiang on March 2000 and is headquartered in West Conshohocken, PA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of YDO1 is 300.433 CHF — it has increased by 11.75% in the past 24 hours. Watch MADRIGAL PHARMACEU stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange MADRIGAL PHARMACEU stocks are traded under the ticker YDO1.
YDO1 stock has risen by 11.24% compared to the previous week, the month change is a 63.21% rise, over the last year MADRIGAL PHARMACEU has showed a 91.31% increase.
We've gathered analysts' opinions on MADRIGAL PHARMACEU future price: according to them, YDO1 price has a max estimate of 467.83 CHF and a min estimate of 136.82 CHF. Watch YDO1 chart and read a more detailed MADRIGAL PHARMACEU stock forecast: see what analysts think of MADRIGAL PHARMACEU and suggest that you do with its stocks.
YDO1 reached its all-time high on Nov 27, 2024 with the price of 300.433 CHF, and its all-time low was 157.036 CHF and was reached on Sep 13, 2023. View more price dynamics on YDO1 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
YDO1 stock is 10.51% volatile and has beta coefficient of 0.58. Track MADRIGAL PHARMACEU stock price on the chart and check out the list of the most volatile stocks — is MADRIGAL PHARMACEU there?
Today MADRIGAL PHARMACEU has the market capitalization of 6.21 B, it has increased by 4.04% over the last week.
Yes, you can track MADRIGAL PHARMACEU financials in yearly and quarterly reports right on TradingView.
MADRIGAL PHARMACEU is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
YDO1 earnings for the last quarter are −4.17 CHF per share, whereas the estimation was −5.72 CHF resulting in a 27.09% surprise. The estimated earnings for the next quarter are −4.04 CHF per share. See more details about MADRIGAL PHARMACEU earnings.
MADRIGAL PHARMACEU revenue for the last quarter amounts to 52.71 M CHF, despite the estimated figure of 29.32 M CHF. In the next quarter, revenue is expected to reach 76.30 M CHF.
YDO1 net income for the last quarter is −90.64 M CHF, while the quarter before that showed −136.63 M CHF of net income which accounts for 33.66% change. Track more MADRIGAL PHARMACEU financial stats to get the full picture.
No, YDO1 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 4, 2024, the company has 376.00 employees. See our rating of the largest employees — is MADRIGAL PHARMACEU on this list?
Like other stocks, YDO1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MADRIGAL PHARMACEU stock right from TradingView charts — choose your broker and connect to your account.